[Federal Register Volume 68, Number 63 (Wednesday, April 2, 2003)]
[Notices]
[Pages 16090-16091]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-7834]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 26, 2002, and published in the Federal 
Register on December 10, 2002, (67 FR 75863), Noramco, Inc., 1440 
Olympic Drive, Athens, Georgia 30601, made application by letter to the 
Drug Enforcement Administration to be registered as a bulk manufacturer 
of the basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Sufentanil (9740)..........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substance for 
sale to a customer.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Noramco, Inc., to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Noramco Inc., to ensure that the 
company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of

[[Page 16091]]

controlled substances listed above is granted.

    Dated: March 11, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-7834 Filed 4-1-03; 8:45 am]
BILLING CODE 4410-09-M